Comparative antioxidant activity of various ophthalmic product types for artificial tears under different experimental conditions

Jurja,Sanda; Negreanu‑Pirjol,Ticuta; Vasile,Monica; Hincu,Mihaela; Ciuluvica,Radu; Negreanu‑Pirjol,Bogdan-Stefan

doi:10.3892/etm.2022.11259

Comparative antioxidant activity of various ophthalmic product types for artificial tears under different experimental conditions

Authors:
- Sanda Jurja
- Ticuta Negreanu‑Pirjol
- Monica Vasile
- Mihaela Hincu
- Radu Ciuluvica
- Bogdan-Stefan Negreanu‑Pirjol
View Affiliations

Affiliations: Faculty of Medicine, ‘Ovidius’ University of Constanta, 900470 Constanta, Romania, Faculty of Pharmacy, ‘Ovidius’ University of Constanta, 900470 Constanta, Romania, Faculty of Medicine, ‘Dunarea de Jos’ University, 800010 Galati, Romania, Faculty of Medical Dentistry, ‘Carol Davila’ University of Medicine and Pharmacy, 010221 Bucharest, Romania
Published online on: March 15, 2022 https://doi.org/10.3892/etm.2022.11259
Article Number: 330
Copyright: © Jurja et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Artificial tears or lubricants is a developing category in pharmaceutical research, due to the permanent increasing incidence of dry eye syndrome caused by the extensive use of personal computers and other gadget screens, associated with global warming and pollution. Considering the role of inflammation in dry eye syndrome, characterized by the production of free radicals, it is imperative to determine which elements are more significant in forming an artificial tear more effectively and more comfortably for the eye state and for the quality of life. Thus, the aim of the present study was to examine the evolution of the total antioxidant capacity of some frequently commercialized artificial tears via the photochemiluminescence method, using an antioxidant capacity of lipid soluble substances procedure, prior and subsequent to the exposure of these therapy agents to some physical agents. This is a preliminary research aiming to evaluate the impact of various environmental factors on these ophthalmic products, to be continued by evaluating whether the effectiveness of these products, in terms of objective examination and patient preference and adherence criteria, is impacted by the conditions of use and storage. Thus, the total antioxidant capacity of the evaluated artificial tear samples after UVC irradiation at 254 nm wavelength was studied, in order to investigate whether their status suffered any change in terms of antioxidant potential. In addition to the findings obtained in the study, some recommendations were also made.

View Figures

View References

1	Mehra D and Galor A: Digital screen use and dry eye: A review. Asia Pac J Ophthalmol (Phila). 9:491–497. 2020.PubMed/NCBI View Article : Google Scholar
2	Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E and Goto E: The challenge of dry eye diagnosis. Clin Ophthalmol. 2:31–55. 2008.PubMed/NCBI View Article : Google Scholar
3	Salmon J: Kanski's Clinical Ophthalmology: A Systematic Approach. 9th edition. Elsevier, pp190-230, 2019.
4	Nelson JD: Dry eye. Br J Ophthalmol. 81(426)1997.PubMed/NCBI View Article : Google Scholar
5	Javadi MA and Feizi S: Dry eye syndrome. J Ophthalmic Vis Res. 6:192–198. 2011.PubMed/NCBI
6	McMonnies CW: Why the symptoms and objective signs of dry eye disease may not correlate. J Optomol. 14:3–10. 2021.PubMed/NCBI View Article : Google Scholar
7	de Araújo DML and Galera PD: Ocular lubricants: What is the best choice? Ciência Rural. 46:2055–2063. 2016.
8	Rouen PA and White ML: Dry eye disease: Prevalence, assessment, and management. Home Health Now. 36:74–83. 2018.PubMed/NCBI View Article : Google Scholar
9	Phadatare SP, Momin M, Nighojkar P, Askarkar S and Singh KK: A comprehensive review on dry eye disease: Diagnosis, medical management, recent developments, and future challenges. Adv Pharm J. 2015:1–12. 2015.
10	Aragona P, Giannaccare G, Mencucci R, Rubino P, Cantera E and Rolando M: Modern approach to the treatment of dry eye, a complex multifactorial disease: A.P.I.C.A.S.S.O. board review. Br J Ophthalmol. 105:446–453. 2021.PubMed/NCBI View Article : Google Scholar
11	Shiraishi A and Sakane Y: Assessment of dry eye symptoms: Current trends and issues of dry eye questionnaires in Japan. Invest Ophthalmol Vis Sci. 59:DES23–DES28. 2018.PubMed/NCBI View Article : Google Scholar
12	Lin H and Yiu SC: Dry eye disease: A review of diagnostic approaches and treatments. Saudi J Ophthalmol. 28:173–181. 2014.PubMed/NCBI View Article : Google Scholar
13	Pucker AD, Ng SM and Nichols JJ: Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev. 2(CD009729)2016.PubMed/NCBI View Article : Google Scholar
14	She Y, Li J, Xiao B, Lu H, Liu H, Simmons PA, Vehige JG and Chen W: Evaluation of a novel artificial tear in the prevention and treatment of dry eye in an animal model. J Ocul Pharmacol Ther. 31:525–530. 2015.PubMed/NCBI View Article : Google Scholar
15	Jurja S, Negreanu-Pirjol T and Negreanu-Pirjol BS: Comparative antioxidant activity of some ocular tissue lubricants from Romanian market. In: Proceedings of the 17th International Multidisciplinary Scientific GeoConferences-SGEM, Albena, pp593-600, 2017.
16	Jurja S, Negreanu-Pirjol T, Negreanu-Pirjol B-S and Roncea FN: UV Radiations influence on the total antioxidant capacity of artificial tears (ocular lubricant). In: Proceedings of the 16th International Multidisciplinary Scientific GeoConferences-SGEM, Sofia, pp395-402, 2016.
17	Jurja S, Negreanu-Pirjol T, Lepadatu AC, Sirbu R and Negreanu-Pirjol BS: Different artificial tears, different eyes. How to choose? In: Proceedings of the 15th International Multidisciplinary Scientific GeoConferences-SGEM, Albena, pp405-410, 2015.
18	Jurja S, Coman M and Hincu MC: The ultraviolet influence upon soft eye tissues. Rom J Morphol Embryol. 58:45–52. 2017.PubMed/NCBI
19	Jurja S, Hincu M, Dobrescu MA, Golu AE, Balasoiu AT and Coman M: Ocular cells and light: Harmony or conflict? Rom J Morphol Embryol. 55:257–261. 2014.PubMed/NCBI
20	Buckley RJ: Assessment and management of dry eye disease. Eye. 32:200–203. 2018.PubMed/NCBI View Article : Google Scholar
21	Hantera MM: Trends in dry eye disease management worldwide. Clin Ophthalmol. 15:165–173. 2021.PubMed/NCBI View Article : Google Scholar
22	Tomlinson A, Madden LC and Simmons PA: Effectiveness of dry eye therapy under conditions of environmental stress. Curr Eye Res. 38:229–236. 2013.PubMed/NCBI View Article : Google Scholar
23	Simpson TL, Situ P, Jones LW and Fonn D: Dry eye symptoms assessed by four questionnaires. Optom Vis Sci. 85:692–699. 2008.PubMed/NCBI View Article : Google Scholar
24	Willshire C, Buckley RJ and Bron AJ: Estimating basal tear osmolarity in normal and dry eye subjects. Cont Lens Anterior Eye. 41:34–46. 2018.PubMed/NCBI View Article : Google Scholar
25	Choy CK, Cho P and Benzie IF: Antioxidant content and ultraviolet absorption characteristics of human tears. Optom Vis Sci. 88:507–511. 2011.PubMed/NCBI View Article : Google Scholar
26	Rieger G: Anti-oxidative capacity of various artificial tear preparations. Graefes Arch Clin Exp Ophthalmol. 239:222–226. 2001.PubMed/NCBI View Article : Google Scholar
27	Abelson M, Ousler G and Stein L: Oxidative stress reduction for dry eye. Antioxidants' effects on harmful reactive oxygen species may be helpful in the fight against dry eye. Rev Ophthalmol. 33:96–115. 2016.
28	Daxer A, Blumthaler M, Schreder J and Ettl A: Effectiveness of eye drops protective against ultraviolet radiation. Ophthalmic Res. 30:286–290. 1998.PubMed/NCBI View Article : Google Scholar
29	Ribeiro MVMR, Barbosa FT, Ribeiro LEF, Sousa-Rodrigues CF and Ribeiro EAN: Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: A systematic review. Arq Bras Oftalmol. 82:436–445. 2019.PubMed/NCBI View Article : Google Scholar
30	Seen S and Tong L: Dry eye disease and oxidative stress. Acta Ophthalmol. 96:e412–e420. 2018.PubMed/NCBI View Article : Google Scholar
31	Jurja S, Pirjol TN, Costea DO and Pirjol BSN: Correlation between effectiveness and antioxidant activity of some anti cataract eye drops. Rev Chim (Bucharest). 67:1004–1007. 2016.
32	Jurja S, Negreanu-Pirjol T, Roncea F, Negreanu-Pirjol BS, Sîrbu R, Lepadatu AC and Miresan H: Correlation between antioxidant activity of vegetal supplement and age related maculopathy. In: Proceedings of the 14th International Multidisciplinary Scientific GeoConferences, Surveying Geology & mining Ecology Management-SGEM, Albena, pp321-328, 2014.
33	Jurja S, Negreanu-Pirjol T, Roncea F, Negreanu-Pirjol BS, Paraschiv G and Miresan H: Aging effect on ocular tissues of antioxidant vegetal supplements from Romanian market. In: Proceedings of the 14th International Multidisciplinary Scientific GeoConferences ‘Surveying Geology & mining Ecology Management-SGEM, Albena, pp225-230, 2014.
34	Manjunath M, Anjali Gowda DV, Kumar P, Srivastava A, Osmani RA, Shinde C and S Hatna: Guar Gum and its pharmaceutical and biomedical applications. Adv Sci Eng Med. 8:1–14. 2016.
35	Bouyer E, Mekhloufi G, Rosilio V, Grossiord JL and Agnely F: Proteins, polysaccharides, and their complexes used as stabilizers for emulsions: Alternatives to synthetic surfactants in the pharmaceutical field? Int J Pharm. 436:359–378. 2012.PubMed/NCBI View Article : Google Scholar
36	Wu H, Du S, Lu Y, Li Y and Wang D: The application of biomedical polymer material hydroxy propyl methyl cellulose (HPMC) in pharmaceutical preparations. J Chem Pharm Res. 6:155–160. 2014.
37	Al-Tabakha MM: HPMC capsules: Current status and future prospects. J Pharm Pharm Sci. 13:428–442. 2010.PubMed/NCBI View Article : Google Scholar
38	Li CL, Martini LG, Ford JL and Roberts M: The use of hypromellose in oral drug delivery. J Pharm Pharmacol. 57:533–546. 2005.PubMed/NCBI View Article : Google Scholar
39	Garrett Q, Simmons PA, Xu S, Vehige J, Zhao Z, Ehrmann K and Willcox M: Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 48:1559–1567. 2007.PubMed/NCBI View Article : Google Scholar
40	Karabinos JV and Hindert M: Carboxymethylcellulose. Adv Carbohydr Chem. 9:285–302. 1954.PubMed/NCBI View Article : Google Scholar
41	Bruix A, Adan A and Casaroli-Marano RP: Efficacy of sodium carboxymethylcellulose in the treatment of dry eye syndrome. Arch Soc Esp Oftalmol. 81:85–92. 2006.PubMed/NCBI View Article : Google Scholar
42	Yao K, Bao Y, Ye J, Lu Y, Bi H, Tang X, Zhao Y, Zhang J and Yang J: Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: Results from a multicenter, open-label, randomized, controlled study. BMC Ophthalmol. 15(28)2015.PubMed/NCBI View Article : Google Scholar
43	Cohen S, Martin A and Sall K: Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose. Clin Ophthalmol. 8:157–164. 2014.PubMed/NCBI View Article : Google Scholar
44	Labetoulle M, Chiambaretta F, Shirlaw A, Leaback R and Baudouin C: Osmoprotectants, Carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: A randomised controlled trial in moderate to severe dry eye. Eye (Lond). 31:1409–1416. 2017.PubMed/NCBI View Article : Google Scholar
45	Popov I and Lewin G: Antioxidative homeostasis: Characterization by means of chemiluminescent technique. Methods Enzymol. 300:437–456. 1999.PubMed/NCBI View Article : Google Scholar
46	Popov IN and Lewin G: Photochemiluminescent detection of antiradical activity; IV: Testing of lipid-soluble antioxidants. J Biochem Biophys Methods. 31:1–8. 1996.PubMed/NCBI View Article : Google Scholar
47	Popov IN and Lewin G: Photosensitized Chemiluminescence. Labo. 8:498–527. 1997.
48	Dinardo JC, Lewis JA, Neudecker BA and Maibach HI: Antioxidants compared in a new protocol to measure protective capacity against oxidative stress-part II¹. J Am Acad Dermatol. 50 (Suppl)(P30)2004.
49	Pegg RB, Amarowicz R, Naczk M and Shahidi F: Photochem for determination of antioxidant capacity of plant extract,. 2007, ACS Symposium Series 956:140-158, Publisher: American Chemical Society, In book: Antioxidant Measurement and Applications, pp.140-158, DOI:10.1021/bk-2007-0956.ch011.
50	Bartollino S, Palazzo M, Semeraro F, Parolini B, Caruso C, Merolla F, Guerra G and Costagliola C: Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits. Int Ophthalmol. 40:925–933. 2020.PubMed/NCBI View Article : Google Scholar
51	Palazzo M, Vizzarri F, Ondruška L, Rinaldi M, Pacente L, Guerra G, Merolla F, Caruso C and Costagliola C: Corneal UV protective effects of a topical antioxidant formulation: A pilot study on in vivo rabbits. Int J Mol Sci. 21(5426)2020.PubMed/NCBI View Article : Google Scholar
52	Ivanov IV, Mappes T, Schaupp P, Lappe C and Wahl S: Ultraviolet radiation oxidative stress affects eye health. J Biophotonics. 11(e201700377)2018.PubMed/NCBI View Article : Google Scholar
53	Cejka C and Cejkova J: Oxidative stress to the cornea, changes in corneal optical properties, and advances in treatment of corneal oxidative injuries. Oxid Med Cell Longev. 2015(591530)2015.PubMed/NCBI View Article : Google Scholar